123 related articles for article (PubMed ID: 12494029)
1. [Significance of trimetazidine for out of hospital physical rehabilitation after myocardial infarction].
Aronov DM; Tartakovskiĭ LB; Novikova NK; Pisareva NA; Smolenskiĭ VS; Zhidko NI
Kardiologiia; 2002; 42(11):14-20. PubMed ID: 12494029
[No Abstract] [Full Text] [Related]
2. [Trimetazidine (Preductal). A new approach in controlling myocardial ischemia].
Eliseev OM
Ter Arkh; 1996; 68(8):57-63. PubMed ID: 9019836
[No Abstract] [Full Text] [Related]
3. [Enhancement of antioxidant status of the elderly patients with ischemic heart disease in response to amino acid composition of MP-33 in combined therapy with trimetazidine].
Kalinina EB; Komissarova IA; Zaslavskaia RM; Zhdanov IuA
Klin Med (Mosk); 2002; 80(5):50-3. PubMed ID: 12087889
[TBL] [Abstract][Full Text] [Related]
4. Trimetazidine in the myocardial cell mechanisms of cytoprotection.
Labrid C
Rom J Intern Med; 1998; 36(3-4):137-44. PubMed ID: 10822510
[TBL] [Abstract][Full Text] [Related]
5. [Myocardial cytoprotection with trimetazidine in patients with ischemic heart disease during surgical stress].
Afanas'eva IV; Goncharova LL; Miroshnichenko AG; Petrash VV; Pokrovskaia LA
Vestn Khir Im I I Grek; 1999; 158(5):34-7. PubMed ID: 10645577
[TBL] [Abstract][Full Text] [Related]
6. [Treating ischemic heart disease by pharmacologically improving cardiac energy metabolism].
Lopaschuk GD
Presse Med; 1998 Dec; 27(39):2100-4. PubMed ID: 9893703
[TBL] [Abstract][Full Text] [Related]
7. [The effects of trimetazidine on left ventricular function and physical exercise tolerance in patients with ischemic cardiomyopathy].
Sisakian AS; Torgomian AL; Barkhudarian AL
Klin Med (Mosk); 2006; 84(10):55-8. PubMed ID: 17201276
[TBL] [Abstract][Full Text] [Related]
8. The potential benefits of trimetazidine in patients with diabetes and ischemic cardiomyopathy.
Korantzopoulos P; Kountouris E; Siogas K; Galaris D
Am Heart J; 2004 Dec; 148(6):e31; author reply e32. PubMed ID: 15632868
[No Abstract] [Full Text] [Related]
9. [Correction of episodes of transitory myocardial ischemia with trimetazidine in patients with ischemic heart disease combined with type 2 diabetes mellitus].
Petriĭ VV; Mikova NV; Makolkin VI
Kardiologiia; 2007; 47(7):22-5. PubMed ID: 18260890
[TBL] [Abstract][Full Text] [Related]
10. [Efficacy of long-term therapy with trimetazidine in patients with ischemic heart disease in combination with chronic obstructive pulmonary disease].
Kolomoets NM; Baksheev VI; Zarubina EG; Uvaĭsova IU
Kardiologiia; 2008; 48(2):47-51. PubMed ID: 18261009
[No Abstract] [Full Text] [Related]
11. [Potentialities of cytoprotection in the treatment of chronic heart failure in patients with coronary heart disease].
Fedorova TA; Il'ina IuV; Sotnikova TI; Rybakova MK
Klin Med (Mosk); 2004; 82(11):15-20. PubMed ID: 15656392
[TBL] [Abstract][Full Text] [Related]
12. Metabolic treatment of myocardial ischaemia.
Ferrari R
Eur Heart J; 1999 Aug; 20(16):1144-5. PubMed ID: 10448019
[No Abstract] [Full Text] [Related]
13. Comments on EMIP-FR study's editorial.
Szwed H
Eur Heart J; 2001 Aug; 22(15):1359. PubMed ID: 11465969
[No Abstract] [Full Text] [Related]
14. [Clinical efficacy of myocardial cytoprotector trimetazidine in peri- and postmenopausal women with ischemic heart disease].
Churshin AD; Pimenov LT
Kardiologiia; 2003; 43(8):31-5. PubMed ID: 14593380
[TBL] [Abstract][Full Text] [Related]
15. Effect of trimetazidine on quality of life in elderly patients with ischemic dilated cardiomyopathy.
Marazzi G; Gebara O; Vitale C; Caminiti G; Wajngarten M; Volterrani M; Ramires JA; Rosano G; Fini M
Adv Ther; 2009 Apr; 26(4):455-61. PubMed ID: 19396409
[TBL] [Abstract][Full Text] [Related]
16. Trimetazidine and reduction in mortality and hospitalization in patients with ischemic dilated cardiomyopathy: a post hoc analysis of the Villa Pini d'Abruzzo Trimetazidine Trial.
Di Napoli P; Di Giovanni P; Gaeta MA; Taccardi AA; Barsotti A
J Cardiovasc Pharmacol; 2007 Nov; 50(5):585-9. PubMed ID: 18030070
[TBL] [Abstract][Full Text] [Related]
17. Effects of trimetazidine on mitochondrial respiratory function, biosynthesis, and fission/fusion in rats with acute myocardial ischemia.
Shi W; Shangguan W; Zhang Y; Li C; Li G
Anatol J Cardiol; 2017 Sep; 18(3):175-181. PubMed ID: 28761019
[TBL] [Abstract][Full Text] [Related]
18. Myocardial metabolic manipulation: a new therapeutic approach in heart failure?
O'Meara E; McMurray JJ
Heart; 2005 Feb; 91(2):131-2. PubMed ID: 15657211
[TBL] [Abstract][Full Text] [Related]
19. Can metabolic manipulation reverse myocardial dysfunction?
Cokkinos DV
Eur Heart J; 2001 Dec; 22(23):2138-9. PubMed ID: 11913472
[No Abstract] [Full Text] [Related]
20. [Assessment of Efficacy and Safety of Metabolic Therapy With Trimetazidine MB in Patients With Ischemic Heart Disease and Chronic Heart Failure].
Gorbunova ML; Vilkova AV
Kardiologiia; 2016 Mar; 56(3):67-72. PubMed ID: 28294892
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
